BR9713699A - Preparado cosmético com um aditivo de peptìdio e utilização do mesmo - Google Patents

Preparado cosmético com um aditivo de peptìdio e utilização do mesmo

Info

Publication number
BR9713699A
BR9713699A BR9713699-9A BR9713699A BR9713699A BR 9713699 A BR9713699 A BR 9713699A BR 9713699 A BR9713699 A BR 9713699A BR 9713699 A BR9713699 A BR 9713699A
Authority
BR
Brazil
Prior art keywords
peptide
ratio
peptide derivative
cosmetic preparation
active components
Prior art date
Application number
BR9713699-9A
Other languages
English (en)
Inventor
Karin Gloz-Berner
Leonhard Zastrow
Nouha Dimloge
Original Assignee
Lancaster Group Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster Group Gmbh filed Critical Lancaster Group Gmbh
Publication of BR9713699A publication Critical patent/BR9713699A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

<B><MU>PREPARADO COSMéTICO COM UM ADITIVO DE PEPTìDIO E UTILIZAçãO DO MESMO<MV><D>. A presente invenção refere-se a um novo preparado cosmético que contém derivados de peptídio a partir de (-MSH, bem como outros componentes ativos. Um produto cosméticos tem de ser desenvolvido que seja dotado da propriedade de ativar o melanogêno e de ser antiinflamatório e de atuar mais eficientemente. O preparado sinergicamente ativo também inclui uma combinação de um derivado de peptídeo correspondente à fórmula [Lip]X-His-Phe-Arg-Y, numa proporção de 0,05 a 2,5 mg de um derivado de peptídeo puro por kg de massa total, enquanto o dito derivado de peptídeo se encontra associado com xantina numa proporção de 0,5 a 2 mols ppr 100 mols de peptídio; pelo menos 0,5 peso total % de uma mistura de enzimas e vitaminas, contendo pelo menos 150 U/ml de superóxido dismutase, e os agentes auxiliares e de suporte usuais numa proporção de 65 a 99,5 peso tota %, e eventualmente outros componentes aditivos.
BR9713699-9A 1996-12-12 1997-12-12 Preparado cosmético com um aditivo de peptìdio e utilização do mesmo BR9713699A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19653736A DE19653736C2 (de) 1996-12-12 1996-12-12 Kosmetisches Präparat mit Peptidzusatz
PCT/DE1997/002941 WO1998025584A2 (de) 1996-12-12 1997-12-12 Kosmetisches präparat mit peptidzusatz

Publications (1)

Publication Number Publication Date
BR9713699A true BR9713699A (pt) 2000-05-09

Family

ID=7815824

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713699-9A BR9713699A (pt) 1996-12-12 1997-12-12 Preparado cosmético com um aditivo de peptìdio e utilização do mesmo

Country Status (11)

Country Link
US (1) US6245342B1 (pt)
EP (1) EP0949902B1 (pt)
JP (1) JP2001507680A (pt)
CN (1) CN1094342C (pt)
AT (1) ATE223196T1 (pt)
BR (1) BR9713699A (pt)
CA (1) CA2271919A1 (pt)
DE (2) DE19653736C2 (pt)
EA (1) EA199900469A1 (pt)
ES (1) ES2182146T3 (pt)
WO (1) WO1998025584A2 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19860754B4 (de) * 1998-06-24 2004-10-28 Coty B.V. Kosmetische Zubereitung
DE19830004B4 (de) * 1998-06-24 2004-08-19 Coty B.V. Kosmetische Wirkstoffzubereitung mit hohem Radikalschutzfaktor und deren Verwendung
FR2781157B1 (fr) * 1998-07-15 2000-08-25 Oreal Composition anti-inflammatoire
FR2823112B1 (fr) * 2001-04-09 2004-03-05 Oreal Produit bronzant et filtrant
EP1521735A2 (en) * 2001-05-25 2005-04-13 Ceremedix, Inc Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
JP3611542B2 (ja) * 2001-11-21 2005-01-19 株式会社ノエビア 油性化粧料
MC200053A1 (fr) * 2002-01-04 2002-07-29 A M Exsymol S Utilisation de derives de la L-arginine comme agents photoprotecteurs et optimisant la reponse melanique dans des compositions cosmetiques
FR2835528B1 (fr) * 2002-02-01 2004-03-12 Inst Europ Biolog Cellulaire Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
US7737119B2 (en) * 2002-03-18 2010-06-15 Societe D'extraction Des Principes Actifs S.A. Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
FR2837098B1 (fr) * 2002-03-18 2004-05-28 Vincience Composition cosmetique ou pharmaceutique comprenant des peptides, procedes de traitement et utilisations
US7025951B2 (en) * 2002-06-18 2006-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for darkening the skin
AU2003246240A1 (en) * 2002-07-03 2004-01-23 Kao Corporation Allergen inactivator
ATE505199T1 (de) * 2002-11-08 2011-04-15 Soc Extraction Principes Actif Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
WO2005032505A1 (de) * 2003-09-22 2005-04-14 Juvena (International) Ag Haut- und haarpflegezubereitung enthaltend eine kombination aus proteinhydrolysaten
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
FR2870242B1 (fr) * 2004-05-11 2010-08-20 Inst Europeen Biologie Cellulaire Peptides ou conjugues peptidiques derives de la msh et leur utilisation dans le traitement cosmetique de la canitie.
FR2870244B1 (fr) 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
FR2870243B1 (fr) * 2004-05-11 2010-11-19 Centre Nat Rech Scient Conjugues tripeptidiques agonistes de la msh
DE102004041573A1 (de) * 2004-08-26 2006-03-02 Henkel Kgaa Neues Mittel zur Behandlung keratinischer Fasern
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
US20070020220A1 (en) 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
DE102005021805B3 (de) * 2005-05-04 2006-10-05 Lancaster Group Gmbh Kosmetisches Verfahren zur Körpermodellierung mit Sonnenschutz und Modellierungs-Set
DE102005026164A1 (de) * 2005-06-06 2006-12-14 Henkel Kgaa Selbstbräunungszusammensetzungen mit UV-Schutzwirkung
CN1319515C (zh) * 2005-07-12 2007-06-06 沈阳何氏生物工程有限公司 活肤眼霜
FR2889808B1 (fr) 2005-08-17 2011-07-22 Oreal Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
DE102005041445A1 (de) * 2005-08-31 2007-03-01 Henkel Kgaa Quarz in kosmetischen Mitteln
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2904551B1 (fr) * 2006-08-03 2012-10-19 Soc Extraction Principes Actif Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
FR2904552B1 (fr) * 2006-08-03 2012-09-21 Soc Extraction Principes Actif Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
DE102007004916A1 (de) 2007-01-26 2008-07-31 Coty Prestige Lancaster Group Gmbh Antifalten-Kosmetikum auf Basis von Peptiden
JP5363344B2 (ja) * 2007-02-14 2013-12-11 ホルモス メディカル リミテッド 治療に有用なトリフェニルブテン誘導体の調製方法
US7504530B2 (en) * 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
DE102007055008A1 (de) 2007-11-14 2009-06-10 Coty Prestige Lancaster Group Gmbh Kosmetisches Produkt zum Schutz der Haut gegen Umwelteinflüsse
FR2994387B1 (fr) 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
WO2014060639A1 (en) 2012-10-19 2014-04-24 Fermion Oy A process for the preparation of ospemifene
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
CN103520058B (zh) * 2013-10-18 2015-03-25 山东省农业科学院农产品研究所 一种蚕蛹活性多肽晒后修复凝露及其制备方法
DE102017108110A1 (de) 2017-04-13 2018-10-18 Neo Cos Service GmbH Kosmetisches Produkt zum Schutz der Haut
FR3095345B1 (fr) 2019-04-29 2021-11-12 Strand Cosmetics Europe Composition cosmetique comprenant une matrice polymerique
DE102021109376A1 (de) 2021-04-14 2022-10-20 Fh Münster Hautpflege- und/oder Hautbehandlungsmittell

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202236A (en) * 1984-09-13 1993-04-13 Enzon Labs Inc. Method of producing bioadhesive protein
DE3721190C1 (de) * 1987-06-26 1989-02-02 Heyl Chem Pharm Kosmetisches Mittel
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
DE4241154C1 (de) * 1992-12-07 1994-03-17 Lancaster Group Ag Verfahren zum Aufschluß von Zelldispersionen oder Zellsuspensionen mittels Ultraschallbehandlung zwecks Gewinnung von Zellinhaltsstoffen
KR100287578B1 (ko) * 1992-12-09 2001-05-02 히라타 다다시 N - 아실글루타민 유도체
US5885564A (en) * 1993-08-13 1999-03-23 Lancaster Group Gmbh Functional oxygenated composition containing phospholipids and fluorocarbon
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
FR2747044B1 (fr) * 1996-04-03 1998-06-26 Coletica Utilisation de graines de vegetaux apres germination comme source de superoxyde dismutase et compositions cosmetiques, pharmaceutiques ou agroalimentaires contenant une telle superoxyde dismutase vegetale, et procede d'extraction

Also Published As

Publication number Publication date
EP0949902A2 (de) 1999-10-20
ATE223196T1 (de) 2002-09-15
EP0949902B1 (de) 2002-09-04
ES2182146T3 (es) 2003-03-01
WO1998025584A2 (de) 1998-06-18
US6245342B1 (en) 2001-06-12
EA199900469A1 (ru) 2000-02-28
CA2271919A1 (en) 1998-06-18
DE19653736C2 (de) 2002-11-21
DE19653736A1 (de) 1998-06-18
WO1998025584A3 (de) 1998-08-20
JP2001507680A (ja) 2001-06-12
DE59708148D1 (de) 2002-10-10
CN1094342C (zh) 2002-11-20
CN1237896A (zh) 1999-12-08

Similar Documents

Publication Publication Date Title
BR9713699A (pt) Preparado cosmético com um aditivo de peptìdio e utilização do mesmo
AP1253A (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate.
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
BG104477A (en) Improved forms against sweating and preparations containing them
MY115339A (en) Compositions containing micronized nebivolol
MY116665A (en) Camptothecin derivatives
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
HUP0101708A2 (hu) 1,2-Hexándiolt tartalmazó izzadásgátló készítmények
ES2071925T3 (es) Composiciones detergentes.
BG103047A (en) Granulate for the preparation of quick decomposition and quick dissolving compositions having high medicamentous form content
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
MY101784A (en) Novel pharmacological compounds
TR200003688T1 (tr) Glutation&#39;un absorbsıyonu&#39;nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
HK1023508A1 (en) Stabilized tibolone compositions.
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
NZ337178A (en) Substituted succinic acid surfactants and their use as thickeners in personal care compositions
AU1572301A (en) Cyclopentyl sulfonamide derivatives
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
KR970032819A (ko) 미백화장료 조성물
TR200003142T2 (tr) Yeni oktahidro-6,10-diokso-6H-piridazino [1,2-A] [1,2] diazepin-1-karboksilik asit türevleri.
EA199900510A1 (ru) Инъекционное лекарственное средство &#34;цитофлавин&#34;, обладающее цитопротекторным действием

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61Q 1/10 (2006.01), A61K 8/64 (2006.0